The European Association for the Study of Obesity (EASO) has called for GLP-1 agonists from Novo Nordisk and Eli Lilly to be ...

MADRID — Individuals with type 2 diabetes and/or obesity plus one or more metabolic risk factors are at a higher risk for metabolic dysfunction–associated steatotic liver disease (MASLD) with fibrosis ...

Gastroenterologist Dr. Naga Chalasani Leads Development of Guidelines for Nonalcoholic Fatty Liver Disease The Indiana University School of Medicine has announced gastroenterologist Naga Chalasani, ...

Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...

The American Gastroenterological Association, the American Association for the Study of Liver Diseases and the American College of Gastroenterology have jointly issued a new practice guideline for ...

COLUMBUS, Ohio — Global Fatty Liver Day is observed on June 12, and there is a growing effort to raise awareness on what is described as one of the most underdiagnosed and misunderstood health threats ...

Heme oxygenase 1 (HO-1) has an influential yet insufficiently investigated effect on Sirtuin 1 (SIRT1), a histone deacetylase activated by nicotinamide adenine dinucleotide, which may impact the ...

Fatty liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), is a growing health concern, affecting an estimated 30.2% of the world's population. Prevalence varies by region, with ...